Restriction endonuclease in situ digestion (REISD) and fluorescence in situ hybridization (FISH) as complementary methods to analyze chimerism and residual disease after bone marrow transplantation

Cancer Genetics and Cytogenetics

Volumn 89, Issue 2, 1996, Pages 141-145

  Gosalvez J ^c   Lopez Fernandez C ^d   Buno I ^d   Polo, N ^a   Llamas, P ^a   Fernandez M N ^a   Fernandez J L ^b   Diez Martin J L ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b Centro Oncologico de Galicia   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

RESTRICTION ENDONUCLEASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHIMERA; CHROMOSOME REARRANGEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030586202     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00181-6     Document Type: Article

References (24)

1. 1. McCann SR, Lawler M (1993): Mixed chimerism; detection and significance following BMT. Bone Marrow Transplant 11:91-94.
2. 2. Bertheas MF, Lafage M, Levy P, Blaire D, Stoppa AM, Viens P, Mannoni P, Maraninchi D (1991): Influence of mixed chimerism on the results of allogenic bone marrow transplantation for leukemia. Blood 78:3103-3106.
3. 3. Bar BMAM, Schattenberg A, van Dijk BA, de Man AJM, Kunst VAJM, de Witte T (1989): Host and donor erythrocyte repopulation patterns after allogenic bone marrow transplantation analyzed with antibody fluorescent microspheres. Br J Haematol 72:239-245.
4. 4. Witherspoon RP, Schanfield MS, Storb ED, Giblett ER (1978): Immunoglobulin production of donor origin after marrow transplantation for acute leukemia or aplastic anemia. Transplantation 26:407-408.
5. 5. Lawler SD, Baker MN, Harris H, Morgenstern GR (1984): Cytogenetic studies on recipients of allogenic bone marrow using sex chromosomes as markers of cellular origin. Br J Haematol 56:431-443.
6. 6. Arthur CK, Apperley JF, Guo AP, Rassol F, Gao LM, Goldman JM (1988): Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase. Blood 71:1179-1186.
7. 7. Arnoldus EPJ, Wiegant J, Noordermeer IA, Wessels JW, Beverstock GC, Grosveld GC, van der Ploeg M, Raap AK (1990). Detection of the Philadelphia chromosome in interphase nuclei. Cytogenet Cell Genet 54:108-111.
8. 8. Nylund SJ, Ruutu T, Saarinen U, Larramendy ML, Knuutila S (1994): Detection of minimal residual disease using fluorescence DNA in situ hybridization: a follow up study in leukemia lymphoma patients. Leukemia 8:587-594.
9. 9. Mindem MD, Messner HA, Belch A (1985): Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism. J Clin Invest 75:91-93.
10. 10. Min GL, Hibbin J, Arthur C, Apperley J, Jeffreys A, Goldman J (1988): Use of minisatellite DNA probes for recognition and characterization of relapse after allogenic bone marrow transplantation. Br J Haematol 68:195-201.
11. 11. Roth MS, Antin JH, Bingham FL, Ginsburg D (1990): Use of polymerase chain reaction detected sequence polymorphism to document engraftment following allogenic bone marrow transplantation. Transplantation 49:714-720.
12. 12. Sawyers CL, Timsom L, Kawasaki ES, Clark SS, Witte ON, Champlin R (1990): Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by the polymerase chain reaction. Proc Natl Acad Sci USA 87:563-572.
13. 13. Potter MN, Cross NCP, Van Dongen JJM, Saglio G, Oakhill A, Bartram CR, Goldman JM (1993): Molecular evidence of minimal residual disease after treatment for leukemia and lymphoma: an update meeting report and review. Leukemia 7:1302-1314.
14. 14. López-Fernández C, Gosálvez J, Ferrucci L, Mezzanotte R (1991): Restriction endonucleases in the study of eukaryotic chromosomes. Genetica 83:257-274.
15. 15. Torre de la J, López-Fernández C, Gosálvez J, Bella JL (1993): Restriction endonucleases: powerful tools to induce chromosome markers. Biochem System Ecol 21:13-24.
16. 16. Gosálvez J, López-Fernández C, Díez-Martin JL (1994): A versatile new method to analyze chimerism following bone marrow transplantation based on "in situ" digestion with restriction endonucleases (abstract). Blood 84 (suppl 1):501.
17. 17. Soler J, Mateu R (1994): Metodología en el estudio de la enfermedad mínima residual. Sangre 39 (suppl 1):35-37.
18. 18. Calabrese G, Stuppia L, Franchi PG, Peila R, Morizio E, Liberati AM, Spadano A, Di Lorenzo R, Donti E, Antonucci A, Palka G (1994): Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis. Cancer Genet Cytogenet 78:153-159.
19. 19. Durnam DM, Anders KR, Fisher L, O'Quigley J, Bryant EM, Thomas ED (1989): Analysis of the origin of bone marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood 74:2220-2226.
20. 20. Lawler M, Humphries P, McCann SR (1991): Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction. Blood 77:2504-2514.
21. 21. Cross NCP, Feng L, Martiat P, O'Shea P, Hughes TP, Goldman JM (1993): Association of MRD detected by PCR after BMT for CML with GVHD and relapse. 19th Annual Meeting EBMT & 9th Meeting of the Nurse Group, Abstract 1604.
22. 22. Díez-Martin JL, López-Fernández C, Buño I, Mason P, Polo N, Fernández MN, Llamas P, Fernández JL, Gosálvez J (1994): Restriction endonucleases in situ digestion (REISD) and fluorescence in situ hybridization to detect residual disease and chimerism after bone marrow transplantation (abstract). Blood 84 (suppl 1):336.
23. 23. Díez-Martín JL, Buño I, López-Fernández C, Fernández MN, Polo N, Gosálvez J: Restriction endonuclease in situ digestion (REISD): a novel quantitative sex-independent method to analyze chimerism after bone marrow transplantation. Exper Hematol (in press).
24. 24. Babu A (1988): Heterogeneity of heterochromatin of human chromosomes as demonstrated by restriction of endonuclease treatment. In: Verma RS (ed.): Heterochromatin. New York, Cambridge University Press, pp. 250-275.